Home NDC 0093-3040 Aspirin and Dipyridamole
Product NDC 0093-3040
11-digit product format 000933040
Labeler code 0093
Product ID 0093-3040_a26cc488-fda2-4c47-9237-a4a7d7aa773d
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Aspirin and Dipyridamole
Dosage form CAPSULE, EXTENDED RELEASE
Route ORAL
Labeler Teva Pharmaceuticals USA, Inc.
Application NDA020884
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2015-07-01
Marketing end 2019-09-30
Substance ASPIRIN; DIPYRIDAMOLE
Active strength 25 mg/1; mg/1
Pharmacologic classes Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020884-001 AGGRENOX ASPIRIN; DIPYRIDAMOLE 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE, EXTENDED RELEASE / ORAL RLD 1999-11-22
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 N020884-001 AGGRENOX 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** CAPSULE, EXTENDED RELEASE / ORAL RLD 1999-11-22 a50c72e98297…